Melissa Barker‐Haliski at School of Pharmacy University of Washington Seattle Washington USA - Research Interests, Publications & Academic Profile

Melissa Barker‐Haliski

University Name

United States

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Turkish students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Neurology

40%

Neuropsychology

20%

Neuropharmacology

80%

Epileptology

60%

Clinical Neurophysiology

40%

Mouse Genetics

30%

Neurochemistry

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Impact of Chronic Seizures on Neuropsychiatric Comorbidities in AD-Associated Models

Open Date: 2020-09-15

Close Date: 2025-05-31

Grant: Close

Role of Alzheimer's disease-associated risk genes on seizure susceptibility

Open Date: 2019-07-01

Close Date: 2020-11-01

Articles11

Diet composition and sterilization modifies intestinal microbiome diversity and burden of Theiler's virus infection–induced acute seizures

Article Link

Year:

2024

Frontline Sodium Channel-Blocking Antiseizure Medicine Use Promotes Future Onset of Drug-Resistant Chronic Seizures

Article Link

Year:

2023

A companion to the preclinical common data elements for rodent models of pediatric acquired epilepsy: A report of the TASK3‐WG1B, Pediatric and Genetic Models Working Group of the ILAE/AES Joint Translational Task Force

Article Link

Year:

2022

A companion to the preclinical common data elements for rodent genetic epilepsy models. A report of the TASK3‐WG1B: Paediatric and genetic models working group of the ILAE/AES joint translational TASK force

Article Link

Year:

2022

Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease

Article Link

Year:

2022

Reductions in Hydrogen Sulfide and Changes in Mitochondrial Quality Control Proteins Are Evident in the Early Phases of the Corneally Kindled Mouse Model of Epilepsy

Article Link

Year:

2022

Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital

Article Link

Year:

2021

Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation

Article Link

Year:

2021

Continuous seizure emergency evoked in mice with pharmacological, electrographic, and pathological features distinct from status epilepticus

Article Link

Year:

2021

Diurnal burden of spontaneous seizures in early epileptogenesis in the post-kainic acid rat model of epilepsy

Article Link

Year:

2021

Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening

Article Link

Year:

2020

Collaborators7

Aristea Galanopoulou

Professor

Albert Einstein College of Medicine

UNITED STATES

Karen Wilcox

Chair/Professor

University of Utah

UNITED STATES

Massimo Mantegazza

FRANCE

Bridgette Semple

Associate Professor

MONASH UNIVERSITY

AUSTRALIA

Dimitri De Bundel

Vrije Universiteit Brussel

BELGIUM

Ilse Smolders

Vrije Universiteit Brussel

BELGIUM

Maxime Vande Vyver

Vrije Universiteit Brussel

BELGIUM

How do Turkish students reach out?

Meet Kite AI